No profile data available.
Edesa Biotech, Inc. (EDSA) is a healthcare company in the lung treatment pharmaceuticals industry, based in Markham, Canada, with about 17 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$7.19 million. In Q1 2026 (the quarter ended December 31, 2025) revenue was $0. Its market capitalization was $47.43 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
Edesa Biotech reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$47.43 million as of October 9, 2026.
Listed companies of a similar size in the same industry (lung treatment pharmaceuticals) include Sionna Therapeutics, Inc. (SION), Rein Therapeutics Inc. (RNTX), Pliant Therapeutics, Inc. (PLRX), aTyr Pharma, Inc. (ATYR).